Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction - Implications for patients with and without recognized diabetes

被引:496
作者
Kosiborod, M
Rathore, SS
Inzucchi, SE
Masoudi, FA
Wang, YF
Havranek, EP
Krumholz, HM
机构
[1] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA
[3] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA
[4] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA
[5] Yale Univ, Sch Med, Sect Hlth Policy & Adm, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA
[6] Yale Univ, New Haven Hlth Ctr Outcomes Res & Evaluat, New Haven, CT USA
[7] Denver Hlth Med Ctr, Dept Med, Div Cardiol, Denver, CO USA
关键词
diabetes mellitus; elderly; glucose; mortality; myocardial infarction;
D O I
10.1161/CIRCULATIONAHA.104.517839
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - The relationship between admission glucose levels and outcomes in older diabetic and nondiabetic patients with acute myocardial infarction is not well defined. Methods and Results - We evaluated a national sample of elderly patients (n = 141 680) hospitalized with acute myocardial infarction from 1994 to 1996. Admission glucose was analyzed as a categorical (<= 110, > 110 to 140, > 140 to 170, > 170 to 240, > 240 mg/dL) and continuous variable for its association with mortality in patients with and without recognized diabetes. A substantial proportion of hyperglycemic patients (eg, 26% of those with glucose > 240 mg/dL) did not have recognized diabetes. Fewer hyperglycemic patients without known diabetes received insulin during hospitalization than diabetics with similar glucose levels (eg, glucose > 240 mg/dL, 22% versus 73%; P < 0.001). Higher glucose levels were associated with greater risk of 30-day mortality in patients without known diabetes ( for glucose range from > 110 to > 240 mg/dL, 10% to 39%) compared with diabetics ( range, 16% to 24%; P for interaction < 0.001). After multivariable adjustment, higher glucose levels continued to be associated with a graded increase in 30-day mortality in patients without known diabetes ( referent, glucose <= 110 mg/dL; range from glucose > 110 to 140 mg/dL: hazard ratio [HR], 1.17; 95% CI, 1.11 to 1.24; to glucose > 240 mg/dL: HR, 1.87; 95% CI, 1.75 to 2.00). In contrast, among diabetic patients, greater mortality risk was observed only in those with glucose > 240 mg/dL ( HR, 1.32; 95% CI, 1.17 to 1.50 versus glucose <= 110 mg/dL; P for interaction < 0.001). One-year mortality results were similar. Conclusions - Elevated glucose is common, rarely treated, and associated with increased mortality risk in elderly acute myocardial infarction patients, particularly those without recognized diabetes.
引用
收藏
页码:3078 / 3086
页数:9
相关论文
共 58 条
  • [51] Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus
    Stranders, I
    Diamant, M
    Van Gelder, RE
    Spruijt, HJ
    Twisk, JWR
    Heine, RJ
    Visser, FC
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (09) : 982 - 988
  • [52] TANSEY MJB, 1983, LANCET, V2, P419
  • [53] Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes
    Tenerz, Å
    Norhammar, A
    Silveira, A
    Hamsten, A
    Nilsson, G
    Rydén, L
    Malmberg, K
    [J]. DIABETES CARE, 2003, 26 (10) : 2770 - 2776
  • [54] Intensive insulin therapy in critically ill patients.
    Van den Berghe, G
    Wouters, P
    Weekers, F
    Verwaest, C
    Bruyninckx, F
    Schetz, M
    Vlasselaers, D
    Ferdinande, P
    Lauwers, P
    Bouillon, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (19) : 1359 - 1367
  • [55] Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction - The glucose-insulin-potassium study: A Randomized trial
    van der Horst, ICC
    Zijlstra, F
    van't Hof, AWJ
    Doggen, CJM
    de Boer, MJ
    Suryapranata, H
    Hoorntje, JCA
    Dambrink, JHE
    Gans, ROB
    Bilo, HJG
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (05) : 784 - 791
  • [56] Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?
    Wahab, NN
    Cowden, EA
    Pearce, NJ
    Gardner, MJ
    Merry, H
    Cox, JL
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (10) : 1748 - 1754
  • [57] Hyperglycemia: still an important predictor of adverse outcomes following AMI in the reperfusion era
    Wong, VW
    Ross, DL
    Park, K
    Boyages, SC
    Cheung, NW
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 64 (02) : 85 - 91
  • [58] STRESS HYPERGLYCEMIA AND CAUSE OF DEATH IN NONDIABETIC PATIENTS WITH MYOCARDIAL-INFARCTION
    YUDKIN, JS
    OSWALD, GA
    [J]. BRITISH MEDICAL JOURNAL, 1987, 294 (6574) : 773 - 773